Homocysteine CAS 6027-13-0

Homocysteine CAS 6027-13-0

Identification Safety Data Specifications & Other Information Links Quick Inquiry Identification CAS Number 6027-13-0 Name Homocysteine Synonyms L-Homocysteine [ACD/Index Name] [ACD/IUPAC Name] (2S)-2-amino-4-sulfanylbutanoic acid (S)-2-amino-4-mercapto-Butanoic acid (S)-2-Amino-4-mercaptobutanoic acid (S)-2-Amino-4-mercaptobutyric acid (S)-homocysteine 0LVT1QZ0BA 227-891-0 [EINECS] 6027-13-0 [RN] Homocysteine [ACD/Index Name] [ACD/IUPAC Name] [Wiki] Homocysteine, L- L-Homocystein [German] [ACD/IUPAC Name] L-Homocystéine [French] [ACD/IUPAC Name] (2S)-2-amino-4-mercaptobutanoic acid (2S)-2-amino-4-mercapto-butyric…

Read More
Ionic Liquid

Ionic Liquid

Ionic liquids are salts which are fluid at ambient temperatures. They have several advantages over conventional molecular solvents, which make them environmentally compatible: Dissolves many different inorganic and organic materials Highly polar Consist of loosely co-ordinating bulky ions Very low vapour pressure Liquid window of up to 300 ºC enabling wide kinetic control Most liquids…

Read More
Nucleoside & Nucleotide

Nucleoside & Nucleotide

ULCHO is one of main suppliers globally for nucleotides and their analogues. We have more than 300 of natural and modified nucleotides available in stock. We can do Natural nucleotides and modified analogues, such as non-hydrolyzable derivatives, nucleotides containing fluorescent groups or halogen atoms and much more. Libraries of Nucleotide analogues for drug screening and…

Read More
Carbohydrate

Carbohydrate

ULCHO can professionally offer custom synthesis of carbohydrates, such as carbohydrate-based intermediates, carbohydrate-based drugs and glycosidase substrates, with good quality, competitive prices and fast delivery. Our advantages Specialty. Rich experience in synthesis carbohydrate; High grade. Effect quality control by NMR、HPLC、EE.、Optical Rotation etc; Reasonable price. Mature product line with the industrialization of the production process allows…

Read More